Professor Mirim Jin has been selected for a new research and development project in the "Future Infectious Disease Technology Development" category of the "2026 Bio and Medical Technology Development Program," organized by the Ministry of Science and ICT and administered by the National Research Foundation of Korea (NRF).

This program is a national R&D initiative aimed at securing core source technologies in promising future bio fields such as new drugs, stem cells, and advanced medical foundational technologies. Among these, the "Future Infectious Disease Technology Development" category supports the development of source technologies including vaccines, therapeutics, and diagnostic technologies to proactively respond to future infectious disease threats.
 

Professor Jin will carry out research on "Development of Novel Modality Therapeutics for Responding to Future Viral Infections" from April 2026 to December 2030. This project aims to proactively address viral infectious diseases that may emerge in the future through the development of novel modality-based therapeutics that overcome the limitations of existing treatment approaches. Through this research, the team aims to contribute to securing and commercializing source technologies for novel therapeutics in response to future infectious diseases.